Cadre EV/EBIT CDRE

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2022.

Today, Oct 23, 2026: 23.2×
4-year median: 24.5×
Against its 4-year history: 36th; percentile: 0 is its lowest day, 100 its highest
4-year range: 18.0× to 81.3×
Peer median: 29.4×

Cadre's EV/EBIT is 23.2× as of Oct 23, 2026.

That is below its 4-year median of 24.5×, close to the middle of its last 4 years.

Over that time it ranged from 18.0× in Apr 2025 to 81.3× in Nov 2022.

The median for 10 medical instruments and supplies stocks of a similar size is 29.4×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	23.2×	19.9×	27.0×
2025	24.4×	18.0×	31.9×
2024	26.3×	22.2×	28.9×
2023	23.4×	20.3×	66.7×
2022	57.8×	57.7×	81.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Cadre's size, closest first, today.

Company	EV/EBIT
CDRECadre	23.2×
BVSBioventus	26.2×
STAAStaar Surgical	57.7×
EYENational Vision	19.2×
IRMDIradimed	37.7×
LMATLemaitre Vascular	22.6×
INSPInspire Medical Systems	32.6×
UFPTUFP Technologies	24.9×
MOVMovado	11.8×
MDXGMimedx	51.6×
ATRCAtriCure	208×
Peer median	29.4×

Where Cadre ranks

#27of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Cadre

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.